Tohen Mauricio
Epidemiol Psichiatr Soc. 2007 Jul-Sep;16(3):197-8.
The author offers a perspective on the perceived conflicts of interest that influence scientific collaborations between academic psychiatry and the pharmaceutical industry. The author holds the position that the merits of a particular study should be judged based on the quality of the scientific methodology rather than on the credentials of the investigators or the source of funding.
作者就影响学术精神病学与制药行业之间科学合作的利益冲突认知提供了一种观点。作者认为,一项特定研究的价值应基于科学方法的质量来评判,而非基于研究者的资质或资金来源。